Overview
- 29 inspections across 27 sites are on record.
- 39 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2011-08-25.
At a glance
Inspections
29
Sites
27
Observations
39
Career since
Jul 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Celgene Corporation | 25 Aug 2011 | On file | |
| Ranbaxy Inc. | 22 Jun 2011 | View 483 → | |
| Celgene Corporation | 17 Jun 2011 | ||
| Orgenus Pharma, Inc. | 18 Apr 2011 | ||
| Waintraub, Stanley E. MD | 18 Mar 2011 | On file |
Sites inspected
Celgene CorporationBerkeley Heights, United States1 insp.
Ranbaxy Inc.Princeton, United States1 insp.
Celgene CorporationSummit, United States1 insp.
Orgenus Pharma, Inc.Princeton, United States1 insp.
Waintraub, Stanley E. MDHackensack, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Dawn L Wydner4 shared
Frederick Razzaghi3 shared
Denise M Visco2 shared
Karen E Dorazio1 shared
Meredith L Sheridan1 shared
Hitesh R Patel1 shared
Addam S Reynolds1 shared
Justine Tomasso1 shared
Full investigator report
Get the verbatim findings behind Dorothy J Denes' 39 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site